Both in Biotechnology
Vericel vs Maze Therapeutics
Over the past year VCEL returned +10.4% and MAZE returned −8.6%; their daily moves had a correlation of 0.17.
VCEL +10.4% MAZE −8.6%Growth of $1, one year, split-adjusted
| Metric | VCEL | MAZE |
|---|---|---|
| Price | $40.51 | $30.37 |
| Market cap | $2.07B | $1.69B |
| Today | +0.62% | −3.53% |
| 1 month | +0.9% | +14.9% |
| 6 months | +11.0% | +12.8% |
| Year to date | +12.5% | −26.7% |
| 1 year | +17.3% | −8.6% |
| Revenue growth (YoY) | +22.5% | — |
| Gross margin | 72.8% | — |
| Net margin | 2.8% | — |
| P/E (TTM) | 85.6× | — |
| Price / sales | 6.8× | 84.4× |
| Net cash | $162.5M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 33.0% | 67.1% |
| Short % of float | 11.1% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).